SpaceX Joins Nasdaq-100: Is the Index Riskier Now?
SpaceX joining the Nasdaq-100 could reshape how the index moves. This guide breaks down what that means for investors...
Saving strategies in this approach focus on purposeful allocations, automatic transfers, and regular budget reviews for consistency.
28,655 articlesSpaceX joining the Nasdaq-100 could reshape how the index moves. This guide breaks down what that means for investors...
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Global markets can offer growth outside the U.S. In this guide, we break down why international stocks may outperform...
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Centene's Sarah London, the youngest-ever female Fortune 500 CEO, is steering a bold reinvention of the nation's larg...
A civil social-media debate this spring highlighted a looming fight over who will own payments: Visa or on-chain stab...
SpaceX’s spending mix is shifting. AI takes a bigger slice of the budget than rockets, raising questions for investor...
When a stock pulls back from its highs, investors want to know if the drop is a buying signal or a warning. This guid...
When a CFO sells a sizable chunk of stock, it can raise questions about the company's outlook. This guide breaks down...
In this morning minute, crypto markets buckled as hawkish Fed signals raised rate hike odds. We unpack the drivers, s...
Investors are watching canopy growth's medical marijuana as a potential engine for a rebound. This guide breaks down ...